Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1970 Nov;40(3):373-81.
doi: 10.1111/j.1476-5381.1970.tb10619.x.

Comparative chronotropic activity of beta-adrenoceptive antagonists

Comparative Study

Comparative chronotropic activity of beta-adrenoceptive antagonists

A M Barrett et al. Br J Pharmacol. 1970 Nov.

Abstract

1. Chronotropic dose-response curves (non-cumulative) for beta-adrenoceptive antagonists were constructed from results in rats anaesthetized with pentobarbitone and depleted of catecholamines by pre-treatment with syrosingopine.2. Depletion of catecholamines lowered resting heart rate and reduced the threshold to the chronotropic action of isoprenaline by about 50%. Eight beta-adrenoceptive antagonists produced a dose-dependent chronotropic response but the maximum response was in all cases smaller than that obtained with isoprenaline. The order of activity was dichloroisoprenaline>LB 46>practolol>INPEA>oxprenolol>pronethalol>alprenolol>I.C.I. 45,763 (Kö 592). Propranolol and sotalol were without significant activity. The duration of the chronotropic response to the antagonists was more prolonged than that to isoprenaline. Propranolol caused a parallel shift to the right of the dose-response curves for the agonist effects of the antagonists.3. Estimation of beta-adrenoceptor blocking activity in anaesthetized cats gave an order of activity dissimilar to that found for maximum agonist responses: LB 46 > oxprenolol > alprenolol > propranolol > I.C.I. 45,763 > practolol > dichloroisoprenaline > sotalol > INPEA > pronethalol.4. Consideration of chemical structure and physico-chemical properties did not explain the differences between the agonist activities of the adrenoceptive antagonists.

PubMed Disclaimer

References

    1. Nature. 1966 Oct 1;212(5057):88-90 - PubMed
    1. Life Sci. 1967 Jun 1;6(11):1147-54 - PubMed
    1. Ann N Y Acad Sci. 1967 Feb 10;139(3):673-85 - PubMed
    1. Proc Soc Exp Biol Med. 1966 Jun;122(2):373-9 - PubMed
    1. Acta Pharmacol Toxicol (Copenh). 1967;25:9-40 - PubMed

Publication types

MeSH terms